The present invention relates to a therapeutic or recurrence inhibitor for acute myeloid leukemia, and a leukemia stem cell proliferation inhibitor containing the compound or a salt thereof.石川 文彦斉藤 頼子橋爪 良信甲田 泰子幸瞳
Conclusion rhG - CSF is effective and safe for children withacute myeloid leukemia. 结论应用rhG -CSF 治疗儿童AML是安全而有效的. 互联网 Clinical mainly for the treatment ofacute myeloid leukemia. 用于治疗急性粒细胞白血病. 互联网 Unfortunately, Raphael was soon diagnosed withAcute Myeloid Leukemia( ...
Progress in the understanding of the biology and therapy of acute myeloid leukemia (AML) is occurring rapidly. Since 2017, nine agents have been approved for various indications in AML. These included several targeted therapies like venetoclax, FLT3 inhi
Acute Myeloid Leukemia (AML) is a type of cancer that affects the blood and bone marrow It occurs when the bone marrow, which is responsible for producing blood cells, starts making too many abnormal white blood cells called myeloblasts.
Prior to allogeneic stem cell transplantation for the treatment of acute myeloid leukemia (AML), complete remission is currently still considered the gold standard of care. A Germany-wide clinical trial now shows for the first time that this approach does not benefit disease-free survival or overal...
Acute myeloid leukemia (AML) is the most common acute leukemia in adults, with an incidence of over 20 000 cases per year in the United States alone. Large chromosomal translocations as well as mutations in the genes involved in hematopoietic prolifer
Fig. 2: Treatment algorithm for AML with mutated IDH1 or IDH2. AML, acute myeloid leukemia; IDH, Isocitrate Dehydrogenase; HMA, hypomethylating agent; IDHi, IDH inhibitor; Allo-HSCT, allogeneic hematopoietic stem cell transplant; MRD, minimal or measurable residual disease. Full size image Table...
Cancer vaccines are promising treatments to prevent relapse after chemotherapy in acute myeloid leukemia (AML) patients, particularly for those who cannot tolerate intensive consolidation therapies. Here, we report the development of an AML cell membrane
Combination treatment of acute myeloid leukemia cells with DNMT and HDAC inhibitors: predominant synergistic gene downregulation associated with gene body demethylation.The present invention relates to the use of volasertib, or a pharmaceutically... N Blagitko-Dorfs,P Schlosser,G Greve,... - Nature ...
By analyzing the surface proteome of a wide-ranging sample of acute myeloid leukemia (AML) specimens, researchers identified potential antigens and primitive cell markers representative of AML supgroups. August 17th 2024 AML Treatment Has Shifted Toward More Personalized Approach ...